BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...

The FDA approved Medtronic’s defibrillator that tailors cardiac resynchronization therapy (CRT) to each patient by using an algorithm to adjust pacing. With its ability to confirm if pulses are ...

Separately, the company is also studying placing the novel, small-diameter OmniaSecure defibrillation lead in the left bundle branch (LBB) area, which has the potential to enable physiologic pacing to ...

Dr. Ruskin answers the question: 'Treated By Pacemaker Vs. Defibrillator?' — -- Question: What is the difference between abnormal heart rhythms treated by pacemakers and defibrillators? Answer ...

The goal of the trial was to evaluate atrial pacing compared with minimal ventricular pacing (i.e., back-up pacing) among patients with reduced left ventricular (LV) function and no clinical ...

Criteria to identify appropriate candidates for CRT and CRT-D are based on the experiences gained during clinical trials ( Table II). Trials to date have predominantly included patients with normal ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...

Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy, 4th Edition, by Drs. Kenneth A. Ellenbogen, Bruce L. Wilkoff, G. Neal Kay, and Chu-Pak Lau, helps you deliver superior clinical ...

NEW ORLEANS -- An investigational extravascular implantable cardioverter-defibrillator (ICD) continues to demonstrate it can appropriately shock patients and prevent sudden cardiac death, extended ...

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm Implantable cardioverter defibrillators (ICDs ...